Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
Dr. Hall is internationally recognized for his pioneering work in organoboron chemistry, catalysis, and medicinal chemistry, including the development of DNA repair inhibitors. He currently holds the Tier 1 Canada Research Chair in Boron Chemistry for Catalysis and Drug Discovery, and leads a multidisciplinary research team dedicated to the development of novel synthetic and biological applications of boron-containing compounds.[1]
With over 175 peer-reviewed publications, two books, and 15 book chapters, Dr. Hall's contributions span catalysis, heterocyclic chemistry, and medicinal chemistry. He has mentored more than 75 graduate students and postdoctoral fellows, and his work has been widely cited with over 18,000 citations and an h-index of 70.[2] Among his numerous accolades are the Arthur C. Cope Scholar Award (2024) from the American Chemical Society[3], the R. U. Lemieux Award (2021) from the Canadian Society for Chemistry[4], and a Killam Research Fellowship (2019-2021). He was elected a Fellow of the Royal Society of Canada in 2017. [5]
As part of his role, Dr. Hall will serve on the Scientific and Clinical Advisory Board and provide strategic advice to the Company on its Research and Development agenda, including clinical discovery, synthesis and manufacturing, pre-clinical testing, and clinical translation plans associated with Polynucleotide Kinase 3 Phosphatase (PNKP) Inhibitor Technology NP/A83. He will also collaborate with the Company's scientific and clinical leadership, as well as external partners, to advance oncology-focused innovations.
'Dr. Hall's appointment marks a significant step in bridging advanced synthetic chemistry with translational oncology. His expertise in boron-based drug discovery is uniquely aligned with our mission to develop precision therapies, and we look forward to leveraging his insight as we push our PNKP Inhibitor Technology toward the clinic,' stated Thomas O'Shaughnessy, CEO of Onco-Innovations.
About Onco-Innovations Limited
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours.
ON BEHALF OF ONCO-INNOVATIONS LIMITED,
'Thomas O'Shaughnessy'
Chief Executive Officer
For more information, please contact:
Thomas O'Shaughnessy
Chief Executive Officer
Tel: + 1 888 261 8055
[email protected]
Forward-Looking Statements Caution. This news release contains forward-looking statements relating to the further development, potential commercialization and benefits of the Company's technologies, the prospects of the Company, and the Company's business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'potential', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to further develop, prove out or commercialize its technologies, and other risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
[1] https://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-eng.aspx?profileId=3535#:~:text=Research%20summary,be%20developed%20into%20drug%20candidates.
[2]
[3]
[4]
[5] SOURCE: Onco-Innovations Limited
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
3 minutes ago
- Bloomberg
‘I Won't Be Going': Canadians Explain Their US Boycott to the Central Bank
Canadians say they're ramping up their boycott of US travel and products in response to US President Donald Trump's tariffs, and the country's central bank is taking notice. For the first time ever in its quarterly survey of consumers, the Bank of Canada asked people about their plans for US trips. About 55% of Canadians said they're avoiding or spending less on vacations to US destinations, and roughly a third of said they plan to spend more on domestic travel.
Yahoo
40 minutes ago
- Yahoo
Heart attack patient waits 13 hours in Moncton Hospital ER
Jonah Imeson says he'd heard plenty of stories about people waiting for hours in New Brunswick's emergency rooms and even dying before being seen by a physician, but then he had his own scare and he's still shaken. The 35-year-old graphic designer, with Type 2 diabetes, said he waited 13 hours at the Moncton Hospital ER with chest discomfort, arm pain, nausea, high blood pressure and a sensation like heartburn before he was seen by a doctor, who told him he'd likely had a heart attack and could have died. Imeson's story puts a face to the untold number of patients in New Brunswick who wait far too long in a hospital system that has openly declared a critical state of over-capacity. And although the Moncton Hospital has been left out of a new protocol demanding some hospital patients be fast-tracked into nursing homes — to help free up beds, including those in ERs — Horizon's dashboard paints a troubling picture. It shows wait times in the Moncton Hospital ER, from triage to assessment by a physician, reached 400 minutes (6.6 hours) in June — the highest since April 2022 and well above the national target of 30. That makes Imeson a remarkable outlier in a system already under-performing by a significant margin. From 3 p.m. on June 4 until 4 a.m. the next day, he waited in a room so full, he lost his seat a few times after getting up to vomit and when he went to call his mother. "You always hear stories, then it actually happens to you," he said of his ER experience. Time-stamped text messages tell wait-time story Imeson was able to reconstruct it from the text messages he sent home to his wife and to his parents in Oromocto. He didn't ask them to come to the hospital, he said, because he was concerned about his wife, who had to work the next day, and didn't want to trouble his mother or father. The experience began at 1 p.m., when he was scheduled to see his dietitian on the hospital campus. He reported chest discomfort and a numb sensation in his arm. The dietitian took his blood pressure, and when she got a reading of 210/119, she walked him to the ER herself. At the triage station, Imeson reported that his own father had had a heart attack at 49 and that diabetes ran in the family. Imeson was registered shortly after 3 p.m., then sat down to wait. WATCH | Why a Moncton man fears going to the hospital again: "While I was there, I started sweating profusely," he said. "I had to go to the bathroom a few times and vomit." As the hours ticked by, Imeson updated his mother by text: 4:11 p.m. "168 over 107 pulse is 95." 5:13 p.m. "151 over 92. They gave me some Tylenol" 6:44 p.m. "147 over 78 pulse is 76 I just had to run and throw up again." 7:48 p.m. "148/78 pulse is 76. This heartburn feeling is weird." 9:05 p.m. "153 over 12 pulse 97 *112" 11:11 p.m. "160 over 94 pulse 90. room's filled" As midnight approached, Imeson thought about leaving the hospital, walking down the street and calling an ambulance. "To see if that might rush me in more," he said. "I guess a part of me never would have done that, but it definitely crossed my mind." His mother texted him encouragement, told him to stay and that a doctor would likely see him soon. Shortly after 4 a.m., Imeson saw a physician and was given an electrocardiogram. It was the first time he heard from a doctor that he might have had a heart attack. More tests ensued. "They did the ultrasound and they had mentioned that it appears the bottom section of my heart was damaged." On June 6, Imeson was sent by ambulance to the heart centre at the Saint John Regional Hospital, where he underwent more examinations. "When I went to Saint John and they did the ink dye test, it became more apparent what the situation was with that blocked artery. So that's why … it appeared damaged, because that artery was blocked." Later that day, an ambulance returned Imeson to the Moncton Hospital, and he was discharged June 8. On Monday, June 16, he returned to work, while taking medication. Once he had his "foot in the door" and could speak to doctors, he said, his care was excellent. Cardiologists say heart attacks need immediate attention CBC News contacted Dr. Zeeshan Ahmed, a cardiologist at the University of Ottawa Heart Institute and an assistant professor of medicine at the University of Ottawa, for a better understanding of what happens when a heart attack occurs. He was not asked to diagnose Imeson or comment on his care. Ahmed said heart attacks are caused by the gradual buildup of plaque in the artery and the sudden rupture of that plaque, which then blocks the artery. "And when that specific artery becomes blocked, the portion of the heart muscle it's supplying will have a lack of blood supply, and as a consequence those muscles will start to die," he said. Ideally, patients presenting with heart attack symptoms would receive an electrocardiogram test within 15 minutes of arrival at the hospital. "Someone presents with chest pain, immediately, an ECG within 10 to 15 minutes, and then the physician has to read it," Ahmed said. An ECG is a simple test, where a lead is attached to the patient's chest and the doctor looks at the electricity the heart generates, which helps a diagnosis. Ahmed said chest pain happens when the artery is partially blocked or blocked completely, and it's important for patients who do feel severe chest pain to get medical attention as soon as possible. "The longer they wait, the heart muscle that is not being supplied by blood will eventually die," he said. "And as it dies, it will start to scar." "I urge people to come to the hospital. Don't sit on the symptoms. Don't delay, especially if there are risk factors like a family history of heart disease, high blood pressure, cholesterol, diabetes, or a history of smoking." Ahmed said symptoms include a sensation of chest tightness or discomfort, a feeling the pain or tightness is travelling down one arm or both arms or up to the jaw. Patients may also have sudden sweating or shortness of breath. They might feel lightheaded or nauseous. They might also feel pain in their upper stomach. Horizon Health said it could not comment on Imeson's file for privacy reasons, but provided a written statement from Bonnie Matchett, the network's clinical director of emergency and critical care. "We can confirm a high volume of patients were experiencing high acuity medical needs in Horizon's The Moncton Hospital (TMH) Emergency Department (ED) on this date," Matchett wrote. She said Horizon wants a "positive patient experience," and people concerned about the care they've received should communicate with a Horizon patient representative. Imeson said he's not sure he'll go to the patient advocate. He's focused on recovery. He is also reflecting on what he might have done to get seen more quickly — or whether causing any fuss would have been proper. "I just assumed they were doing the best with what they had and I just stuck through to the end," he said. "But I was concerned if I made a scene, would they ask me to leave? And would it even have been fair for me to do that to them they were as busy as they were."
Yahoo
an hour ago
- Yahoo
Better disaster recovery needed as frequency grows: insurance bureau
The Insurance Bureau of Canada is calling for national discussions about how to better manage rebuilding after disasters as their cost and frequency grow. The bureau is asking the federal government to lead talks with provinces on disaster recovery as efforts to rebuild Jasper, Alta., encounter delays a year after a wildfire destroyed about a third of the town's buildings. IBC says that as of July 7, officials have only issued rebuilding permits for 56 of the 358 buildings that burned down, a much slower process than after the 2016 Fort McMurray wildfires. Part of the complication is the added regulation from the town being in a national park, but IBC says a lack of co-ordinated and standardized response is also an issue. Craig Stewart, vice-president of climate change and federal issues at IBC, says delays in rebuilding are happening more frequently after major disasters so there needs to be more co-ordination such as a central agency to help manage the recovery. The calls come as July 22 marks one year from when the Jasper wildfire caused an estimated $1.2 billion in insured damage, just one of several disasters last year that caused about $8.5 billion in combined insured damage. This report by The Canadian Press was first published July 21, 2025. The Canadian Press
